One possible explanation, thus, is that intensive glucose control has time-limited positive homodynamic effects (up to some days), and that afterward the positive effects of intensive insulin treatment are concealed by a higher complication rate related to adverse events, especially hypoglycemia. The gene discussed is INS; the disease is Hypoglycemia.